Source/Disclosures
Source:

Healio Coverage

September 27, 2020
2 min read
Save

PAD Awareness Month calls attention to amputation risks, screening, treatments

Source/Disclosures
Source:

Healio Coverage

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

September is Peripheral Artery Disease Awareness Month, designed to improve access to screening and treatments for patients with PAD.

According to the CardioVascular Coalition, approximately 20 million Americans have PAD, and about 200,000 patients per year undergo avoidable amputations. Many of these patients are from historically underrepresented backgrounds, according to the coalition.

Breaking News
Source: Adobe Stock.

As part of this year’s PAD Awareness Month activities, the coalition is calling for Congress to block planned cuts to Medicare specialty providers, including vascular surgeons, cardiac surgeons and interventional radiologists, all of whom treat PAD.

To commemorate PAD Awareness Month, Healio and Cardiology Today have compiled a list of recent PAD-related news.

VOYAGER PAD: Treatment effect of rivaroxaban in PAD strongest in concomitant CAD

Among patients with PAD who underwent revascularization, those with concomitant clinical evidence of CAD received greater absolute benefit of reduced risk for MACE from taking low-dose rivaroxaban than those with PAD without CAD. Read more

Depressive symptoms may worsen health status in PAD

Women with PAD were more likely to have depressive symptoms compared with men, researchers found. Read more

CV medications underused by Hispanic/Latino patients with PAD

Hispanic and Latino patients with PAD underuse guideline-recommended CV medications such as antiplatelet and lipid-lowering therapies, researchers found. Read more

Statin therapy less common in PAD than CHD, cerebrovascular disease

Patients with PAD were less likely to be treated with statin therapy compared with those with cerebrovascular disease or CHD despite having a high risk for atherosclerotic CVD events, researchers found. Read more

Diabetes, CLI among factors connected to major amputation in PAD

In an analysis of the EUCLID trial, factors associated with major amputation in PAD included diabetes, prior amputation, critical limb ischemia and an ankle-brachial index of less than 0.8. Read more

ACC, SVS collaborate on registry to improve care of vascular disease

The American College of Cardiology announced a collaboration with the Society for Vascular Surgery focused on a single vascular registry to improve outcomes and care for patients with vascular disease. Read more

Paclitaxel-related mortality risk not observed in Medicare Advantage cohort

In a retrospective, adjusted analysis of Medicare Advantage beneficiaries who underwent peripheral vascular interventions, there was no evidence of an elevated mortality risk due to paclitaxel-coated devices. Read more

Chronic stress after new, worsening PAD diagnosis predicts long-term mortality

Among patients with new or worsening PAD, chronic stress was independently associated with elevated risk for all-cause mortality in the subsequent 4 years, researchers reported. Read more

SCAI advises on optimal device use in aortoiliac interventions

The Society for Cardiovascular Angiography and Interventions released guidelines on selection of devices for aortoiliac arterial interventions. Read more

Alcohol consumption increases risk for PAD, stroke

Higher alcohol consumption predicted by genetics was associated with elevated risk for peripheral artery disease and stroke, according to a study published in Circulation: Genomic and Precision Medicine. Read more